Profile | GDS5420 / 227905_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 531.28 | 68 |
GSM1296119 | B_lesional_pre-dose | 1011.38 | 79 |
GSM1296076 | C_lesional_pre-dose | 654.09 | 73 |
GSM1296092 | D_lesional_pre-dose | 538.8 | 69 |
GSM1296103 | E_lesional_pre-dose | 455.35 | 66 |
GSM1296078 | F_lesional_pre-dose | 745.08 | 75 |
GSM1296107 | G_lesional_pre-dose | 887 | 77 |
GSM1296109 | H_lesional_pre-dose | 682.85 | 73 |
GSM1296080 | I_lesional_pre-dose | 416.05 | 65 |
GSM1296090 | J_lesional_pre-dose | 576.94 | 70 |
GSM1296074 | K_lesional_pre-dose | 800.8 | 76 |
GSM1296111 | L_lesional_pre-dose | 1239.46 | 83 |
GSM1296099 | M_lesional_pre-dose | 708.47 | 73 |
GSM1296086 | O_lesional_pre-dose | 550.2 | 70 |
GSM1296117 | P_lesional_pre-dose | 1204.35 | 82 |
GSM1296113 | Q_lesional_pre-dose | 1161.07 | 82 |
GSM1296096 | R_lesional_pre-dose | 716.5 | 74 |
GSM1296105 | S_lesional_pre-dose | 567.77 | 69 |
GSM1296098 | T_lesional_pre-dose | 552.3 | 69 |
GSM1296101 | U_lesional_pre-dose | 464.99 | 66 |
GSM1296121 | V_lesional_pre-dose | 856.42 | 77 |
GSM1296088 | W_lesional_pre-dose | 399.13 | 64 |
GSM1296082 | X_lesional_pre-dose | 752.2 | 75 |
GSM1296115 | Y_lesional_pre-dose | 1198.54 | 82 |
GSM1296084 | Z_lesional_pre-dose | 412.86 | 65 |
GSM1296072 | B_lesional_day8 | 712.78 | 74 |
GSM1296069 | L_lesional_day8 | 1071.93 | 81 |
GSM1296071 | P_lesional_day8 | 768.39 | 75 |
GSM1296070 | Y_lesional_day8 | 791.25 | 76 |
GSM1296073 | V_lesional_day8 | 819.27 | 76 |
GSM1296034 | A_lesional_day15 | 286.73 | 57 |
GSM1296041 | G_lesional_day15 | 1144.13 | 81 |
GSM1296035 | R_lesional_day15 | 672.01 | 72 |
GSM1296038 | U_lesional_day15 | 635.85 | 72 |
GSM1296047 | B_lesional_day15 | 656.83 | 72 |
GSM1296039 | E_lesional_day15 | 1048.02 | 80 |
GSM1296042 | H_lesional_day15 | 852.15 | 77 |
GSM1296043 | L_lesional_day15 | 854.74 | 77 |
GSM1296037 | M_lesional_day15 | 321.98 | 60 |
GSM1296046 | P_lesional_day15 | 801.17 | 76 |
GSM1296044 | Q_lesional_day15 | 793.94 | 75 |
GSM1296045 | Y_lesional_day15 | 745.03 | 75 |
GSM1296025 | C_lesional_day15 | 256.63 | 57 |
GSM1296033 | D_lesional_day15 | 306.44 | 59 |
GSM1296027 | I_lesional_day15 | 239.84 | 57 |
GSM1296032 | J_lesional_day15 | 310.92 | 59 |
GSM1296024 | K_lesional_day15 | 255.1 | 57 |
GSM1296031 | W_lesional_day15 | 323.59 | 60 |
GSM1296028 | X_lesional_day15 | 328.86 | 61 |
GSM1296029 | Z_lesional_day15 | 307.79 | 59 |
GSM1296026 | F_lesional_day15 | 394.15 | 64 |
GSM1296030 | O_lesional_day15 | 308.23 | 60 |
GSM1296040 | S_lesional_day15 | 397.73 | 63 |
GSM1296036 | T_lesional_day15 | 488.24 | 67 |
GSM1296048 | V_lesional_day15 | 772.27 | 75 |
GSM1296059 | A_lesional_day43 | 521.67 | 68 |
GSM1296066 | G_lesional_day43 | 958.6 | 79 |
GSM1296060 | R_lesional_day43 | 660.56 | 72 |
GSM1296063 | U_lesional_day43 | 811.24 | 76 |
GSM1296064 | E_lesional_day43 | 929.08 | 78 |
GSM1296067 | H_lesional_day43 | 553.3 | 69 |
GSM1296062 | M_lesional_day43 | 490.96 | 67 |
GSM1296068 | Q_lesional_day43 | 986.67 | 79 |
GSM1296050 | C_lesional_day43 | 459.86 | 67 |
GSM1296057 | D_lesional_day43 | 474.71 | 66 |
GSM1296052 | I_lesional_day43 | 255.96 | 57 |
GSM1296054 | J_lesional_day43 | 249.18 | 55 |
GSM1296049 | K_lesional_day43 | 320.89 | 60 |
GSM1296055 | W_lesional_day43 | 435.98 | 65 |
GSM1296053 | X_lesional_day43 | 324.74 | 60 |
GSM1296058 | Z_lesional_day43 | 259.37 | 57 |
GSM1296051 | F_lesional_day43 | 567.57 | 70 |
GSM1296056 | O_lesional_day43 | 558.72 | 70 |
GSM1296065 | S_lesional_day43 | 773.69 | 75 |
GSM1296061 | T_lesional_day43 | 420.15 | 64 |
GSM1296095 | A_non-lesional_pre-dose | 835.01 | 76 |
GSM1296120 | B_non-lesional_pre-dose | 683.61 | 73 |
GSM1296077 | C_non-lesional_pre-dose | 211.3 | 54 |
GSM1296093 | D_non-lesional_pre-dose | 264.31 | 56 |
GSM1296104 | E_non-lesional_pre-dose | 770.6 | 75 |
GSM1296079 | F_non-lesional_pre-dose | 396.09 | 64 |
GSM1296108 | G_non-lesional_pre-dose | 689.04 | 73 |
GSM1296110 | H_non-lesional_pre-dose | 667.46 | 72 |
GSM1296081 | I_non-lesional_pre-dose | 168.66 | 51 |
GSM1296091 | J_non-lesional_pre-dose | 400.69 | 64 |
GSM1296075 | K_non-lesional_pre-dose | 448.56 | 67 |
GSM1296112 | L_non-lesional_pre-dose | 717.63 | 74 |
GSM1296100 | M_non-lesional_pre-dose | 433.38 | 65 |
GSM1296087 | O_non-lesional_pre-dose | 173.12 | 52 |
GSM1296118 | P_non-lesional_pre-dose | 704.68 | 73 |
GSM1296114 | Q_non-lesional_pre-dose | 1006.22 | 80 |
GSM1296097 | R_non-lesional_pre-dose | 561.82 | 70 |
GSM1296106 | S_non-lesional_pre-dose | 597.75 | 70 |
GSM1296102 | U_non-lesional_pre-dose | 287.31 | 57 |
GSM1296122 | V_non-lesional_pre-dose | 806.8 | 76 |
GSM1296089 | W_non-lesional_pre-dose | 324.72 | 60 |
GSM1296083 | X_non-lesional_pre-dose | 319.53 | 60 |
GSM1296116 | Y_non-lesional_pre-dose | 780.19 | 75 |
GSM1296085 | Z_non-lesional_pre-dose | 293.21 | 59 |